Ashat, Divya
Jain, Animesh
Weaver, Kimberly N.
Long, Millie D.
Herfarth, Hans H.
Barnes, Edward L.
Article History
Accepted: 22 August 2022
First Online: 20 September 2022
Declarations
:
: Hans H. Herfarth has served as a consultant for Alivio, AMAG, BMS, ExeGI, Finch, Janssen, Gilead, Lycera, Merck, Otsuka, Pfizer, PureTech, Seres and research support from Pfizer and Artizan Biosciences. Millie D. Long has served as a consultant for AbbVie, UCB, Takeda, Janssen, Pfizer, Salix, Valeant, Target Pharmasolutions and has received research support from Pfizer and Takeda. Kimberly N. Weaver has served as a consultant for AbbVie. Edward L. Barnes has served as a consultant for AbbVie, Pfizer, and Target RWE. Divya Ashat and Animesh Jain have no relevant disclosures for this work.